Deutsche Bank analyst Pito Chickering raised the firm’s price target on ModivCare to $120 from $100 and keeps a Buy rating on the shares following the Q4 results. The analyst sees an attractive setup for the shares into 2024.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MODV: